Cargando…
In silico toxicology models and databases as FDA Critical Path Initiative toolkits
In silico toxicology methods are practical, evidence-based and high throughput, with varying accuracy. In silico approaches are of keen interest, not only to scientists in the private sector and to academic researchers worldwide, but also to the public. They are being increasingly evaluated and appl...
Autor principal: | Valerio, Luis G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500173/ https://www.ncbi.nlm.nih.gov/pubmed/21504870 http://dx.doi.org/10.1186/1479-7364-5-3-200 |
Ejemplares similares
-
IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data
por: Legehar, Ashenafi, et al.
Publicado: (2016) -
ArrayTrack: a free FDA bioinformatics tool to support emerging biomedical research -- an update
por: Xu, Joshua, et al.
Publicado: (2010) -
PathCase-SB architecture and database design
por: Cakmak, Ali, et al.
Publicado: (2011) -
In-silico human genomics with GeneCards
por: Stelzer, Gil, et al.
Publicado: (2011) -
Tripal: a construction toolkit for online genome databases
por: Ficklin, Stephen P., et al.
Publicado: (2011)